Kintor Pharma completes first patient enrollment in long-term safety phase III trial of KX-826
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
PEEK brings a new quality to dental care for patients
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Construction will begin this year with the new capacity anticipated by 2025
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
One thousand times more soluble than L-cystine at neutral pH
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Subscribe To Our Newsletter & Stay Updated